Skip to content

Clinical trials

Lung Neoplasms trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Denmark Clear all

122 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20066
20071
20082
20092
20105
20114
20126
20133
20144
201512
20165
20174
20186
20197
20206
20215
20225
20236
202411
20258
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Recruiting26
Unknown status19
Active, not recruiting10
Terminated10
Not yet recruiting4
Enrolling by invitation3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rigshospitalet, Denmark19
Odense University Hospital7
University of Aarhus7
Vejle Hospital6
Aarhus University Hospital5
University Hospital Schleswig-Holstein5
Aalborg University Hospital4
Eli Lilly and Company4
Zealand University Hospital4
European Organisation for Research and Treatment of Cancer - EORTC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms122
Carcinoma, Non-Small-Cell Lung35
Neoplasms16
Breast Neoplasms8
Colorectal Neoplasms8
Lung Diseases8
Disease7
Head and Neck Neoplasms7
Pulmonary Disease, Chronic Obstructive5
Radiation Injuries5

Trials

Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.

22 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.